Resources
About Us
Home Report
Store
Immunohistochemistry (IHC) Market
Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User - Global Forecast to 2031
Report ID:MRHC - 1041284 Pages: 240 Sep-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursImmunohistochemistry Market Size & Forecast
The Immunohistochemistry Market is anticipated to reach $4.08 billion by 2031 at a CAGR of 7.2% from 2024–2031. A multitude of factors drives the growth of the immunohistochemistry market. These include the increasing prevalence of chronic diseases, particularly among the growing geriatric population, the heightened focus on rare diseases, the growing awareness of the importance of early disease diagnosis, the rising expenditure on research & development, the surging demand for drug discovery & development, the rising incidence of infectious diseases, the mounting funding for research activities, and the increasing healthcare expenditure.
Furthermore, inclination toward personalized medicine, advancements in genomics and proteomics, and increasing automation in immunohistochemistry are expected to offer significant growth opportunities for market growth.
Immunohistochemistry Market Growth Drivers
Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
The prevalence of chronic diseases and conditions such as cancer, diabetes, arthritis, and heart disease are on the rise globally. Cancer is one of the leading causes of death around the world. For instance, the World Health Organisation (WHO) 2022 report states that about 10 million deaths worldwide in 2020 were attributable to cancer, with 1.80 million of those deaths being caused by lung cancer. An increasing number of people are afflicted with chronic diseases, largely due to societal behaviors, including alcohol and tobacco use, physical inactivity, and bad diets, as well as the aging population. The International Diabetes Federation estimates that 6.7 million deaths worldwide in 2021 will be attributed to diabetes. The need for sophisticated laboratory IHC solutions to aid in the more accurate diagnosis of cancer and other diseases is growing due to the rise in chronic diseases and the aging population, which is less resistant to these conditions.
-Market.webp "Immunohistochemistry (IHC) Market")
Click here to: Get Free Sample Pages of this Report
Increasing Research & Development Expenditure
Pharmaceutical companies are continually focusing on R&D, which is a critical component of medication development procedures. The biotechnology industry also makes significant investments in research & development to meet the growing need for innovation and new medical advances. The increasing number of medicine approvals demonstrates the importance of research and development. For example, according to a report published by the European Commission, the European Union would spend USD 374.1 billion on research and development in 2022, up 7% from 2021 and 47.5% from 2012. Furthermore, nations such as India and China are substantially investing in research and development, which is expected to increase demand for advanced research solutions, which in turn is expected to boost the demand for immunohistochemistry products.
Immunohistochemistry Market Trends
AI-Based Histochemistry
AI offers efficient workflow, serves as an additional tool for analysis, and standardizes reports for immunohistochemistry. AI immunohistochemistry is used for tumor diagnosis, which is made easy by the integration of AI. Various companies are providing AI-based software for immunohistochemistry analysis. For Instance, in December 2023, Indica Labs, Inc. (U.S) launched Breast IHC AI, an AI-powered decision support tool. This tool helps in the evaluation and quantification of breast cancer biomarkers, including ER, PR, HER2, and Ki67. Additionally, In March 2023, Visiopharm A/S (Denmark) launched Ki67 algorithm for Immunohistochemistry biomarker analysis. This algorithm provides strong identification of tumor cells, quantification, cell classification, and visualization. Thus, AI in histochemistry is expected to support the growth of the market.
Immunohistochemistry Market Opportunities
Increasing Inclination Towards Personalized Medicine
Personalized medicine utilizes an individual's genomic information to provide personalized therapy. Precision medications not only help to cure diseases, but they also increase the chances of people surviving treatments for life-threatening conditions such as cancer. Cancer is among the main causes of death around the globe. For example, according to a report published by the World Health Organisation in 2022, nearly 10 million people perished from cancer worldwide. Immunohistochemistry aids in the diagnosis of cancer by predicting therapy responses and determining disease consequences (prognoses). As a result, the rising prevalence of cancer is driving up the use of personalized treatment, creating the potential for the immunohistochemistry market to grow.
Advancements in Genomics and Proteomics
Immunohistochemistry (IHC) provides a cost-effective technique for determining the molecular morphology of tissue and cell micro-architecture. IHC uses the Antigen-Antibody interaction for analyzing visualizing, quantifying, and phenotyping cells at a tissue level. Protein profiling done by the use of immunohistochemistry allows the visualization of the distribution of relative proteins in cancer genes present in tumor cells. Some proteins express differently for different forms of cancer. The availability of necessary and specific protein markers aids with accurate tumor diagnosis and classification. Also in genomics, IHC plays an important role in diagnostics, with many biomarkers that the technique can currently detect. Thus, the advancements in genomics and proteomics and the use of IHC in these fields are expected to increase the demand for IHC solutions, which is expected to drive the growth of the market.
Immunohistochemistry Market Analysis: Key Findings
By Offering: In 2024, the Consumables Segment to Dominate the Immunohistochemistry Market
Based on offering, the immunohistochemistry market is segmented into consumables, equipment, and services & software. In 2024, the consumables segment is expected to account for a large share of 68.4% of the immunohistochemistry market. The consumables segment is further sub-segmented into reagents, kits, and other accessories. Advancements in kits and reagents enable laboratories to perform multiple tests simultaneously. Other factors, such as the rising prevalence of chronic diseases and increased genetic and rare disease research by biopharmaceutical companies, contract research organizations, and research laboratories, drive the demand for IHC kits and reagents.
By Method: In 2024, the Avidin-Biotin Complex Segment to Dominate the Immunohistochemistry Market
Based on method, the immunohistochemistry market is segmented into avidin-biotin complex, polymer-based immunohistochemistry, catalyzed signal amplification (CSA), fluorescyl-tyramide amplification, improved catalyzed signal amplification (ICSA), multi-staining immunohistochemistry, labeled streptavidin-biotin (LSAB), and pap method. In 2024, the avidin-biotin complex segment is expected to account for the largest share of 30.8% of the immunohistochemistry market. The large market share of this segment is attributed to the various advantages offered by avidin-biotin complex, which include resistivity to enzymatic reactions, PH changes, temperature, denaturation, and organic reagents, increased detection efficiency, requiring less primary antibody, and less assay time as compared to other methods.
By Application: In 2024, the Clinical Applications Segment to Dominate the Immunohistochemistry Market
Based on application, the immunohistochemistry market is segmented into research applications and clinical applications. In 2024, the clinical applications segment is expected to account for the largest share of the immunohistochemistry market. The clinical applications segment is further sub-segmented into reproductive health, oncology, infectious disease, and other clinical applications. Factors driving the growth of this segment include the increasing incidence of cancer, the rising awareness among healthcare professionals about the advantages of immunohistochemistry testing for treatment purposes, and the increasing number of diagnostic laboratories. For instance, cancer is one of the leading causes of death across the globe. According to WHO, approximately 400,000 children develop cancer per year in the world, increasing the demand for immunohistochemistry tests for the detection of the disease.
By End User: In 2024, the Hospitals & Diagnostic Laboratories Segment to Dominate the Immunohistochemistry Market
Based on end user, the immunohistochemistry market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic institutes & research centers, and other end users. In 2024, the hospitals & diagnostic laboratories segment is expected to account for the largest share of the immunohistochemistry market. This segment’s large market share is attributed to the increasing prevalence of cancer, rising healthcare expenditure, and the growing number of hospitals in both developed and developing countries. Furthermore, more inclination of patients toward hospitals due to developed infrastructure, availability of skilled professionals, and availability of advanced treatments.
Geographical Analysis
In 2024, North America is expected to account for the largest share of 38.4% of the immunohistochemistry market. North America's significant market share is attributed to the presence of key immunohistochemistry technology and product providers, high prevalence of chronic and infectious diseases, high awareness regarding early disease diagnosis, growing adoption of advanced diagnostic products, and rising funding activities coupled with novel developments in clinical and research technologies.
Moreover, Asia-Pacific is poised to register the highest CAGR of 13% during the forecast period. This region’s growth is attributed to continuous improvements in healthcare infrastructure, the rising number of hospitals, and increasing government investments in this sector. Accelerated economic growth in many countries of the Asia-Pacific region has relatively increased the focus of various governments on the healthcare sector in terms of increased investments to enhance the accessibility to healthcare facilities and build better healthcare infrastructure. For instance, according to a report published by the Ministry of Finance of India, for the year 2022-2023 Central and State Governments' budget for healthcare is 2.1% of total gross domestic product (GDP).
Immunohistochemistry Market: Key Companies
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years (2021–2024). The key players operating in the global immunohistochemistry market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC. (U.S.), Bio-Genex Laboratories (U.S.), and CANDOR Bioscience GmbH (Germany).
Immunohistochemistry Industry Overview: Latest Developments from Key Industry Players
- In February 2023, F. Hoffmann-La Roche Ltd (Switzerland) collaborated with Janssen, a division of Johnson & Johnson Pte. Ltd. (U.S.) for precision medicine with various companion diagnostic technologies, which includes digital pathology, immunohistochemistry, next-generation sequencing, immunoassays, and polymerase chain reaction (PCR).
- In January 2023, Agilent Technologies, Inc. (U.S.) partnered with Akoya Biosciences, Inc. (U.S) to develop multiplex-immunohistochemistry diagnostic solutions for the analysis of tissue and for commercializing workflow solutions.
- In October 2022, F. Hoffmann-La Roche Ltd (Switzerland) launched Anti-PRAME (EPR 20330), a Rabbit Monoclonal Primary Antibody. This antibody is used to identify protein expression in tissue samples.
Immunohistochemistry Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
240 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
7.2% |
|
Estimated Market Size (Value) |
$4.08 billion by 2031 |
|
Segments Covered |
By Offering
By Method
By Process
By Application
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa |
|
Key Companies |
F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC. (U.S.), Bio-Genex Laboratories (U.S.), and CANDOR Bioscience GmbH |
Key questions answered in the immunohistochemistry market report:
The global immunohistochemistry market report covers the qualitative analysis and market sizing of offering, method, process, application, and end user. This report involves the analysis of various segments of immunohistochemistry at the regional and country level. The report also provides insights on factors impacting market growth, regulatory analysis, case studies, pricing analysis, regulatory analysis, and Porter’s five forces analysis.
The global immunohistochemistry market is expected to reach $ 4.08 billion by 2031 at a CAGR of 7.2% from 2024 to 2031.
Among all the methods studied, in this report in 2024, the avidin-biotin complex segment is expected to account for the largest share of the immunohistochemistry market. The large share of this segment is attributed to the various advantages, including resistivity to enzymatic reactions, PH changes, temperature, denaturation, and organic reagents, reduced assay time, and high detection efficiency.
Among all the applications studied in this report, in 2024, the clinical applications segment is expected to account for the largest share of the immunohistochemistry market. This segment is sub-segmented into reproductive health, oncology, infectious disease, and other clinical applications. The large share of the segment is attributed to various factors, including the increasing incidence of cancer, the rising awareness among healthcare professionals about the advantages of immunohistochemistry, and an increasing number of diagnostic laboratories.
The growth of this market can be attributed to various factors, such as the rising prevalence of chronic diseases coupled with the increasing geriatric population, increasing focus on rare diseases, rising awareness regarding early disease diagnosis, increasing research and development expenditure, rising demand for drug discovery and development, rising prevalence of infectious diseases, increasing funding for research activities, and rising healthcare expenditure.
Furthermore, increasing inclination towards personalized medicine, advancements in genomics and proteomics, and increasing automation in immunohistochemistry are expected to offer growth opportunities.
The key players operating in the global immunohistochemistry market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC. (U.S.), Bio-Genex Laboratories (U.S.), and CANDOR Bioscience GmbH (Germany)
The countries like China and India are estimated to offer significant growth opportunities for the vendors in this market. Continuous improvements in healthcare infrastructure, the rising number of hospitals, and increasing government investments in the healthcare sector. Accelerated economic growth in many countries of the Asia-Pacific region has relatively increased the focus of various governments on the healthcare sector in terms of increased investments to enhance the accessibility to healthcare facilities and build better healthcare infrastructure. Such developments are expected to drive the growth of the IHC market.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Factors Affecting Market Growth
4.1. Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
4.2.2. Increasing Focus on Rare Disease
4.2.3. Rising Awareness Regarding Early Disease Diagnosis
4.2.4. Increasing Research and Development Expenditure
4.2.5. Rising Demand for Drug Discovery and Development
4.2.6. Rising Prevalence of Infectious Diseases
4.2.7. Increasing Funding for Research Activities
4.2.8. Rising Healthcare Expenditure
4.3. Restraints
4.3.1. Lack of Standardized Protocols
4.4. Opportunities
4.4.1. Increasing Inclination Toward Personalized Medicine
4.4.2. Advancements in Genomics and Proteomics
4.4.3. Increasing Automation in Immunohistochemistry
4.5. Challenges
4.5.1. Availability of Alternative Technology
4.6. Trends
4.6.1. AI-Based Histochemistry
4.6.2. Use of Multiplex IHC
4.7. Factor Analysis
4.8. Case Studies
4.9. Pricing Analysis
4.10. Regulatory Analysis
4.10.1. U.S.
4.10.2. Canada
4.10.3. Europe
4.10.4. China
4.10.5. Japan
4.10.6. India
4.10.7. Latin America
4.10.8. Middle East
4.11. Pricing Analysis
4.12. Porter’s Five Forces Analysis
5. Immunohistochemistry Market Assessment—by Offering
5.1. Overview
5.2. Consumables
5.2.1. Reagents
5.2.1.1. Fixation Reagents
5.2.1.2. Antigen Retrieval
5.2.1.3. Buffers
5.2.1.4. Blocking Reagents
5.2.1.5. Antibodies
5.2.1.6. Control Reagents
5.2.1.7. Chromogenic Substrates
5.2.1.8. Counterstain
5.2.2. Other Accessories
5.3. Equipment
5.3.1. Staining System
5.3.2. Imaging Systems
5.3.3. Slide Scanners
5.3.4. Tissue Microarrays
5.4. Services & Software
6. Immunohistochemistry Market Assessment—by Method
6.1. Overview
6.2. Avidin-Biotin Complex
6.3. Polymer-Based Immunohistochemistry
6.4. Catalyzed Signal Amplification (CSA)
6.5. Fluorescyl-tyramide Amplification
6.6. Improved Catalyzed Signal Amplification (iCSA)
6.7. Multi-Staining Immunohistochemistry
6.8. Labeled Streptavidin Biotin (LSAB)
6.9. PAP Method
7. Immunohistochemistry Market Assessment—by Process
7.1. Overview
7.2. Sample Preparation
7.3. Antigen Retrieval
7.4. Background Blocking
7.5. Target Detection
7.6. Sample Visualization
8. Immunohistochemistry Market Assessment—by Application
8.1. Overview
8.2. Research and Other Applications
8.2.1. Drug Discovery
8.2.2. Agriculture & Animal Research
8.2.3. Other Applications
8.3. Clinical Applications
8.3.1. Reproductive Health
8.3.2. Oncology
8.3.3. Infectious Disease
8.3.4. Other Clinical Applications
9. Immunohistochemistry Market Assessment—by End User
9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Hospitals & Diagnostic Laboratories
9.4. Academic Institutes & Research Centers
9.5. Contract Research Organizations
9.6. Other End Users
10. Immunohistochemistry Market Assessment—by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Middle East & Africa
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Rankings of Key Players (2023)
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
12.1. F. Hoffmann-La Roche Ltd (Switzerland)
12.2. Danaher Corporation (U.S.)
12.3. Agilent Technologies, Inc. (U.S.)
12.4. Merck KGaA (Germany)
12.5. Bio-Rad Laboratories, Inc. (U.S.)
12.6. Eagle Biosciences, Inc. (U.S.)
12.7. Thermo Fisher Scientific Inc. (U.S)
12.8. Cell Signaling Technology, Inc. (U.S.)
12.9. PerkinElmer, Inc. (U.S.)
12.10. Bio SB Inc. (U.S.)
12.11. Biocare Medical, LLC. (U.S.)
12.12. Bio-Genex Laboratories (U.S.)
12.13. CANDOR Bioscience GmbH (Germany)
12.14. Innovex Biosciences Inc. (U.S.)
(Note: SWOT analysis of the top 5 companies will be provided.)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Global Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 2 Global Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 3 Global Immunohistochemistry Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 5 Global Immunohistochemistry Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Immunohistochemistry Fixation Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Immunohistochemistry Antigen Retrieval Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Immunohistochemistry Buffers Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Immunohistochemistry Blocking Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Immunohistochemistry Antibodies Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Immunohistochemistry Control Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Immunohistochemistry Chromogenic Substrates Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Immunohistochemistry Counterstains Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Immunohistochemistry Counterstains Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Other Immunohistochemistry Accessories Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 17 Global Immunohistochemistry Equipment Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Immunohistochemistry Staining Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Immunohistochemistry Imaging Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Immunohistochemistry Slide Scanners Market, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Immunohistochemistry Tissue Microarrays Market, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Immunohistochemistry Services & Software Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 24 Global Avidin-Biotin Complex Market, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Polymer-Based Immunohistochemistry Market, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Catalysed Signal Amplification (CSA) Market, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Fluorescyl-tyramide Amplification Market, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Improved Catalyzed Signal Amplification (iCSA) Market, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Multi-Staining Immunohistochemistry Market, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Labeled Streptavidin Biotin (LSAB) Market, by Country/Region, 2022–2031 (USD Million)
Table 31 Global PAP Method Market, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 33 Global Immunohistochemistry Sample Preparation Market, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Immunohistochemistry Antigen Retrieval Market, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Immunohistochemistry Background Blocking Market, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Immunohistochemistry Target Detection Market, by Country/Region, 2022–2031 (USD Million)
Table 37 Global Immunohistochemistry Sample Visualization Market, by Country/Region, 2022–2031 (USD Million)
Table 38 Global Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 39 Global Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 40 Global Immunohistochemistry Market for Research and Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 41 Global Immunohistochemistry Market for Drug Discovery, by Country/Region, 2022–2031 (USD Million)
Table 42 Global Immunohistochemistry Market for Agriculture & Animal Research, by Country/Region, 2022–2031 (USD Million)
Table 43 Global Immunohistochemistry Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 44 Global Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 45 Global Immunohistochemistry Market for Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 46 Global Immunohistochemistry Market for Reproductive Health, by Country/Region, 2022–2031 (USD Million)
Table 47 Global Immunohistochemistry Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 48 Global Immunohistochemistry Market for Infectious Disease, by Country/Region, 2022–2031 (USD Million)
Table 49 Global Immunohistochemistry Market for Other Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 50 Global Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 51 Global Immunohistochemistry Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 52 Global Immunohistochemistry Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 53 Global Immunohistochemistry Market for Academic Institutes & Research Centers, by Country/Region, 2022–2031 (USD Million)
Table 54 Global Immunohistochemistry Market for Contract Research Organizations, by Country/Region, 2022–2031 (USD Million)
Table 55 Global Immunohistochemistry Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 56 Global Immunohistochemistry Market, by Country/Region, 2022–2031 (USD Million)
Table 57 North America: Immunohistochemistry Market, by Country, 2022–2031 (USD Million)
Table 58 North America: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 59 North America: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 60 North America: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 61 North America: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 62 North America: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 63 North America: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 64 North America: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 65 North America: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 66 North America: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 67 North America: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 68 U.S.: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 69 U.S.: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 70 U.S.: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 71 U.S.: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 72 U.S.: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 73 U.S.: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 74 U.S.: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 75 U.S.: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 76 U.S.: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 77 U.S.: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 78 Canada: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 79 Canada: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 80 Canada: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 81 Canada: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 82 Canada: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 83 Canada: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 84 Canada: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 85 Canada: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 86 Canada: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 87 Canada: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 88 Europe: Immunohistochemistry Market, by Country/Region, 2022–2031 (USD Million)
Table 89 Europe: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 90 Europe: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 91 Europe: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 92 Europe: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 93 Europe: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 94 Europe: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 95 Europe: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 96 Europe: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 97 Europe: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 98 Europe: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 99 Germany: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 100 Germany: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 101 Germany: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 102 Germany: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 103 Germany: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 104 Germany: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 105 Germany: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 106 Germany: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 107 Germany: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 108 Germany: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 109 France: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 110 France: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 111 France: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 112 France: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 113 France: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 114 France: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 115 France: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 116 France: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 117 France: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 118 France: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 119 U.K.: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 120 U.K.: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 121 U.K.: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 122 U.K.: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 123 U.K.: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 124 U.K.: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 125 U.K.: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 126 U.K.: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 127 U.K.: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 128 U.K.: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 129 Italy: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 130 Italy: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 131 Italy: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 132 Italy: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 133 Italy: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 134 Italy: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 135 Italy: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 136 Italy: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 137 Italy: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 138 Italy: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 139 Spain: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 140 Spain: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 141 Spain: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 142 Spain: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 143 Spain: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 144 Spain: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 145 Spain: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 146 Spain: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 147 Spain: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 148 Spain: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 149 Rest of Europe: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 150 Rest of Europe: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 151 Rest of Europe: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 152 Rest of Europe: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 153 Rest of Europe: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 154 Rest of Europe: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 155 Rest of Europe: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 156 Rest of Europe: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 157 Rest of Europe: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 158 Rest of Europe: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 159 Asia-Pacific: Immunohistochemistry Market, by Country/Region, 2022–2031 (USD Million)
Table 160 Asia-Pacific: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 161 Asia-Pacific: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 162 Asia-Pacific: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 163 Asia-Pacific: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 164 Asia-Pacific: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 165 Asia-Pacific: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 166 Asia-Pacific: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 167 Asia-Pacific: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 168 Asia-Pacific: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 169 Asia-Pacific: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 170 Japan: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 171 Japan: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 172 Japan: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 173 Japan: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 174 Japan: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 175 Japan: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 176 Japan: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 177 Japan: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 178 Japan: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 179 Japan: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 180 China: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 181 China: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 182 China: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 183 China: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 184 China: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 185 China: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 186 China: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 187 China: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 188 China: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 189 China: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 190 India: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 191 India: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 192 India: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 193 India: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 194 India: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 195 India: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 196 India: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 197 India: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 198 India: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 199 India: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 200 Australia: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 201 Australia: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 202 Australia: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 203 Australia: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 204 Australia: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 205 Australia: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 206 Australia: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 207 Australia: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 208 Australia: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 209 Australia: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 210 South Korea: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 211 South Korea: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 212 South Korea: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 213 South Korea: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 214 South Korea: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 215 South Korea: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 216 South Korea: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 217 South Korea: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 218 South Korea: Global Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 219 South Korea: Global Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 220 Rest of Asia-Pacific: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 221 Rest of Asia-Pacific: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 222 Rest of Asia-Pacific: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 223 Rest of Asia-Pacific: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 224 Rest of Asia-Pacific: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 225 Rest of Asia-Pacific: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 226 Rest of Asia-Pacific: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 227 Rest of Asia-Pacific: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 228 Rest of Asia-Pacific: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 229 Rest of Asia-Pacific: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 230 Latin America: Immunohistochemistry Market, by Country/Region, 2022–2031 (USD Million)
Table 231 Latin America: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 232 Latin America: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 233 Latin America: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 234 Latin America: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 235 Latin America: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 236 Latin America: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 237 Latin America: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 238 Latin America: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 239 Latin America: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 240 Latin America: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 241 Brazil: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 242 Brazil: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 243 Brazil: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 244 Brazil: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 245 Brazil: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 246 Brazil: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 247 Brazil: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 248 Brazil: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 249 Brazil: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 250 Brazil: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 251 Mexico: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 252 Mexico: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 253 Mexico: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 254 Mexico: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 255 Mexico: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 256 Mexico: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 257 Mexico: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 258 Mexico: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 259 Mexico: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 260 Mexico: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 261 Rest of Latin America: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 262 Rest of Latin America: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 263 Rest of Latin America: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 264 Rest of Latin America: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 265 Rest of Latin America: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 266 Rest of Latin America: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 267 Rest of Latin America: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 268 Rest of Latin America: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 269 Rest of Latin America: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 270 Rest of Latin America: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 271 Middle East & Africa: Immunohistochemistry Market, by Offering, 2022–2031 (USD Million)
Table 272 Middle East & Africa: Immunohistochemistry Consumables Market, by Type, 2022–2031 (USD Million)
Table 273 Middle East & Africa: Immunohistochemistry Reagents Market, by Type, 2022–2031 (USD Million)
Table 274 Middle East & Africa: Immunohistochemistry Equipment Market, by Type, 2022–2031 (USD Million)
Table 275 Middle East & Africa: Immunohistochemistry Market, by Method, 2022–2031 (USD Million)
Table 276 Middle East & Africa: Immunohistochemistry Market, by Process, 2022–2031 (USD Million)
Table 277 Middle East & Africa: Immunohistochemistry Market, by Application, 2022–2031 (USD Million)
Table 278 Middle East & Africa: Immunohistochemistry Market for Research and Other Applications, by Type, 2022–2031 (USD Million)
Table 279 Middle East & Africa: Immunohistochemistry Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 280 Middle East & Africa: Immunohistochemistry Market, by End User, 2022–2031 (USD Million)
Table 281 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Immunohistochemistry Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 8 Global Immunohistochemistry Market, by Method, 2024 VS. 2031 (USD Million)
Figure 9 Global Immunohistochemistry Market, by Process, 2024 VS. 2031 (USD Million)
Figure 10 Global Immunohistochemistry Market, by Application, 2024 VS. 2031 (USD Million)
Figure 11 Global Immunohistochemistry Market, by End User, 2024 VS. 2031 (USD Million)
Figure 12 Global Immunohistochemistry Market, by Geography
Figure 13 Impact Analysis: Immunohistochemistry Market
Figure 14 Global Immunohistochemistry Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 15 Global Immunohistochemistry Market, by Method, 2024 VS. 2031 (USD Million)
Figure 16 Global Immunohistochemistry Market, by Process, 2024 VS. 2031 (USD Million)
Figure 17 Global Immunohistochemistry Market, by Application, 2024 VS. 2031 (USD Million)
Figure 18 Global Immunohistochemistry Market, by End User, 2024 VS. 2031 (USD Million)
Figure 19 Global Immunohistochemistry Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 20 North America: Immunohistochemistry Market Snapshot
Figure 21 Europe: Immunohistochemistry Market Snapshot
Figure 22 Asia-Pacific: Immunohistochemistry Market Snapshot
Figure 23 Latin America: Immunohistochemistry Market Snapshot
Figure 24 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 25 Global Immunohistochemistry Market: Competitive Benchmarking, by Offering
Figure 26 Global Immunohistochemistry Market: Competitive Benchmarking, by Method
Figure 27 Global Immunohistochemistry Market: Competitive Benchmarking, by Geography
Figure 28 Global Immunohistochemistry Market: Competitive Dashboard
Figure 29 Global Immunohistochemistry Market: Market Share Analysis/Market Ranking, By Key Players, 2023
Figure 30 F. Hoffmann-La Roche Ltd: Financial Overview (2023)
Figure 31 Danaher Corporation: Financial Overview (2023)
Figure 32 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 33 Merck KGaA: Financial Overview (2023)
Figure 34 Bio-Rad Laboratories, Inc.: Financial Overview (2023)
Figure 35 Thermo Fisher Scientific Inc.: Financial Overview (2023)
Figure 38 PerkinElmer, Inc.: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Tissue Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Nov-2022
Peripheral Vascular Devices Market - Global Opportunity Analysis And Industry Forecast (2021-2028)
Published Date: Sep-2021
North America Tissue Diagnostics Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jun-2024
